Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SCHOTT Inaugurates New Manufacturing Facility in Serbia | Contract Pharma

What are you searching for?

Sign in
Breaking News

SCHOTT Inaugurates New Manufacturing Facility in Serbia

Increases its competitiveness in the field of drug containment solutions and builds the largest ampoule manufacturing facility in Europe.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

The new production facility in Jagodina.

SCHOTT Pharma has inaugurated a new manufacturing facility in central Serbia.

The company’s investment has been realized with the start of glass ampoule production, which will create around 180 jobs by the end of 2025. With this step, SCHOTT Pharma is increasing its competitiveness in the field of drug containment solutions and is building the largest ampoule manufacturing facility in Europe.

“At a time when global tariffs and duties are rising and other European-based glass ampoule manufacturers are closing their doors, we can offer our regional customers a clear long-term perspective on how to secure their local supply chain,” said Andreas Reisse, CEO of SCHOTT Pharma.

The new site in Jagodina will manufacture glass ampoules for the storage of injectable medications such as analgesics, anti-inflammatories and anesthetics.

SCHOTT Pharma’s new ampoule production in Serbia will continue to help the pharmaceutical industry deliver medicines to patients safely. The facility is equipped with modern manufacturing technology and inspection systems to produce products to the highest quality standards.

SCHOTT Pharma’s Type I borosilicate glass ampoule portfolio ranges from clear or amber glass types to different shapes (B, C, D) and breakage systems (one point cut, scoring, color break) and is available with or without printing. It includes more than a thousand different articles, all manufactured in accordance with current Good Manufacturing Practices (cGMP). To meet the demanding requirements of modern drug manufacturing, SCHOTT Pharma ampoules emphasize uniform dimensions and exceptional cosmetic quality to ensure seamless compatibility with automated filling lines, minimize downtime and reduce waste. As a result, they meet evolving industry standards and requirements and help pharmaceutical companies optimize efficiency and achieve product integrity, contributing to long-term cost savings.

With the new site in Serbia, SCHOTT Pharma adds another location to its global manufacturing network, which now includes 15 countries.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics